Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Armata Pharmaceuticals Inc banner
A

Armata Pharmaceuticals Inc
F:TG1N

Watchlist Manager
Armata Pharmaceuticals Inc
F:TG1N
Watchlist
Price: 6.75 EUR Market Closed
Market Cap: €244m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

TG1N Price Targets Summary
Armata Pharmaceuticals Inc

Wall Street analysts forecast TG1N stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TG1N is 8.7 EUR with a low forecast of 6.46 EUR and a high forecast of 11.19 EUR.

TG1N Lowest Forecast
Wall Street Target
6.46 EUR
-4% Downside
TG1N Average Forecast
Wall Street Target
8.7 EUR
29% Upside
TG1N Highest Forecast
Wall Street Target
11.19 EUR
66% Upside
Lowest
Price Target
6.46 EUR
4% Downside
Average
Price Target
8.7 EUR
29% Upside
Highest
Price Target
11.19 EUR
66% Upside
Armata Pharmaceuticals Inc Competitors:
Price Targets
PTCT
PTC Therapeutics Inc
28% Upside
PRQR
ProQR Therapeutics NV
582% Upside
IDXX
IDEXX Laboratories Inc
23% Upside
FLEX
Flex Ltd
16% Upside
PTCT
PTC Therapeutics Inc
28% Upside
PRQR
ProQR Therapeutics NV
582% Upside
IDXX
IDEXX Laboratories Inc
23% Upside
FLEX
Flex Ltd
16% Upside
BIOX
Bioceres Crop Solutions Corp
246% Upside

Revenue
Forecast

19% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
19% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 12 years the compound annual growth rate for Armata Pharmaceuticals Inc's revenue is 19%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss

What are analyst estimates?

See Also

Summary
TG1N intrinsic value, competitors valuation, and company profile.
DCF Valuation
TG1N stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TG1N stock valuation using valuation multiples.
Wall Street Estimates
TG1N price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TG1N stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TG1N's stock price target?
Price Target
8.7 EUR

According to Wall Street analysts, the average 1-year price target for TG1N is 8.7 EUR with a low forecast of 6.46 EUR and a high forecast of 11.19 EUR.

Back to Top
ALPHA SPREAD
Follow us
Join more than 319,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.